on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has publicly disclosed its position in Mural Oncology plc through a regulatory filing. According to the disclosure, The Vanguard Group holds 727,309 ordinary shares of Mural Oncology plc, which represents 4.21% of the relevant securities. This is in adherence to the Irish Takeover Panel Act, 1997 and Takeover Rules, 2022. The detailed document indicates there have been sales of 43,686 ordinary shares at a price of 2.08 USD per unit.
Furthermore, the filing specifies that there are no cash-settled or stock-settled derivatives, nor are there any agreements to buy or sell securities. Additionally, no indemnities, agreements, or arrangements concerning these securities are in place. This filing provides transparency on Vanguard's stake and trading activities in Mural Oncology.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news